All News Marinomed Biotech AG

Equities

MARI

ATMARINOMED6

Delayed Wiener Boerse Other stock markets 03:44:44 2024-05-29 am EDT			5-day change	1st Jan Change
14.5 ^EUR	+1.05%		-7.05%	-50.34%

Apr. 16	Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024
Apr. 16	Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marinomed Biotech : Remuneration policy for members of the Management Board 2024	04:18am	PU
Marinomed Biotech : Remuneration policy for members of the Supervisory Board 2024	02:08am	PU
AGM: Marinomed Biotech AG: Invitation to the 7th Annual General Meeting on Thursday, June 20, 2024, at 13:00 (Vienna time)	May. 23	EQ
Marinomed Biotech : Update Q1 2024	May. 22	PU
Marinomed Biotech AG announces results for the first quarter of 2024	May. 22	EQ
Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios	Apr. 25	EQ
AFR: Marinomed Biotech AG: Release of a Financial report	Apr. 16	EQ
Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024	Apr. 16
Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets	Apr. 16	EQ
AFR: Marinomed Biotech AG: Release of a Financial report	Apr. 16	EQ
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution	Apr. 15	EQ
Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico	Apr. 11	EQ
Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months	Mar. 28	EQ
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe	Mar. 26	EQ
Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations	Mar. 01	EQ
Marinomed Biotech AG announces preliminary revenue for 2023	Feb. 14	EQ
Marinomed Biotech AG with important progress for Carragelose in 2024	Feb. 07	EQ
Marinomed Biotech Considers Partnerships, Potential Transfer of Carragelose Portfolio	Dec. 18	MT
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio	Dec. 18	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Marinomed Biotech AG

Equities

MARI

ATMARINOMED6

All News

Filters